Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > MRKR Marker Therapeutics > Main Composition
MRKR Marker Therapeutics
0.340
+0.006+1.80%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Single Segment--1.24M100.00%
Region Unit:USD
nameYOYOperating income%
United States--1.24M100.00%
Company Overview More
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
CEO: Mr. Peter L. Hoang
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...